Medicine
neffy 2 mg/100 ul nasal spray
neffy 2 mg/100 ul nasal spray is a prescription medicine containing Epinephrine for nasal use, marketed by ARS Pharmaceuticals Operations, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Neffy freezes below 5°F (-15°C). If neffy freezes, it will not…
Key facts
- Active ingredient (INN)
- Epinephrine
- Brand
- neffy
- Strength
- 2 mg/100 ul
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 2 blister pack, 1 blister pack
- Marketing authorisation holder
- ARS Pharmaceuticals Operations
- Manufacturers
- ARS Pharmaceuticals OperationsMedical Purchasing SolutionsSportpharm
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Neffy freezes below 5°F (-15°C). If neffy freezes, it will not deliver epinephrine. Store at 68°F to 77°F (20°C to 25°C). Excursions permitted up to 122°F (50°C). Store neffy nasal spray in the blister pack until ready to use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AD01 Epinephrine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 August 2024
- Identifiers
- RxCUI 2693442, 2693448, 2709207 +1DailyMed set ID 2052f9db-7d76-443b-b702-b6b499f9a4b8, a1758142-a905-401d-8961-05829f51023a, 2d4063e8-f56c-6902-e063-6294a90a0d40NDC 85766-130, 82580-020, 71872-7330Application NDA214697
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 carton / 1 vial, single-dose in 1 blister pack / 100 ul in 1 vial, single-dose | 82580-020-02 | ARS Pharmaceuticals Operations | 9 August 2024 |
| 1 blister pack in 1 bag / 1 vial, single-dose in 1 blister pack / 100 ul in 1 vial, single-dose | 71872-7330-1 | Medical Purchasing Solutions | 16 January 2025 |
| 2 blister pack in 1 carton / 1 vial, single-dose in 1 blister pack / 100 ul in 1 vial, single-dose | 85766-130-02 | Sportpharm | 6 December 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Epinephrine
Clinical summary
Epinephrine is a catecholamine. It is available as injection, nasal spray and kits for intramuscular, subcutaneous and intravenous use. MedsAcross supplies Epinephrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EpinephrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EPIPEN prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
- Eurneffy: European public assessment report (EPAR) · European Medicines Agency
Need neffy 2 mg/100 ul nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.